MeSH D009103 - multiple sclerosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Methylprednisolone | Methylprednisolone |  | 1982-01-01 |  |  |
| Prednisolone | Prednisolone |  | 1982-01-01 |  |  | |
| Prednisone | Prednisone |  | 1982-01-01 |  |  | |
| AAIPharma | Azathioprine | Azasan |  | 1999-06-07 |  |  |
| Abbott Biotherapeutics | Methylprednisolone | A-methapred |  | 1991-02-22 |  |  |
| AbbVie | Prednisolone | Pred |  | 1982-01-01 |  |  |
| Prednisolone | Pred Mild |  | 1982-01-01 |  |  | |
| Accord Healthcare | Dalfampridine | Dalfampridine |  | 2018-07-11 |  |  |
| Fampridine | Fampridine Accord |  | 2020-09-24 |  |  | |
| Dimethyl fumarate | Dimethyl Accord |  | 2023-02-15 |  |  | |
| ACIC Pharmaceuticals | Baclofen | Baclofen |  | 2023-08-10 |  |  |
| Acorda Therapeutics | Dalfampridine | Ampyra |  | 2010-01-22 | $63.94 M | Y2023 |
| Alcon Research | Prednisolone, Sulfacetamide | Cetapred |  | 1993-08-06 |  |  |
| Prednisolone, Sulfacetamide | Isopto Cetapred |  | 1982-01-01 |  |  | |
| Prednisolone | Prednisolone |  | 1991-10-24 |  |  | |
| Alembic Pharmaceuticals | Cyclophosphamide | Cyclophosphamide |  | 2022-11-10 |  |  |
1
2
3
4
5
6
...
16
>
Clinical Trials
Historical Success Rate
Phase 1
76%68/90
Phase 2
45%60/133
Phase 3
58%71/123
Approved: 31Overall Success rate: 20%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
11
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use